A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...
Players like Kerry Goode. The pride of Hazelwood High School once dreamed of plunging into the endzone and helping his team ...
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a Michigan Medicine-led study suggests.
Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...